A股異動 | 天原股份漲4.5% 年產10萬噸磷酸鐵鋰正極材料一體化項目已取得投資備案表
格隆匯5月12日丨天原股份漲4.5%,報9.75元,總市值76億元。天原股份昨晚披露年產10萬噸磷酸鐵鋰正極材料一體化項目的進展公吿,公司決定一體化項目中的磷酸、磷酸鐵項目將由全資子公司海豐和泰作為項目建設主體。項目擬在2022年內開工建設,工期預計18個月。成立子公司宜賓天原鋰電新材有限公司作為一體化項目中磷酸鐵鋰項目建設主體,項目擬在2022年3季度內開工建設,工期預計18個月。目前上述一體化各項目均已取得《四川省固定資產投資備案表》,前期準備工作正在順利推進中,力爭儘早開工。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.